BioCentury
ARTICLE | Clinical News

Fycompa perampanel: Phase III data

December 7, 2015 8:00 AM UTC

The double-blind, Asian Phase III Study 335 in 710 patients ages >=12 with refractory partial-onset seizures who were receiving 1-3 antiepileptic drugs showed that once-daily 8 and 12 mg oral Fycompa ...